AFT Pharmaceuticals announced a capital raising today to support liquidity and optimise its capital structure. AFT is undertaking an underwritten placement, comprised of: • a primary placement to raise approximately NZ$10 million by issue of new shares in AFT; and • a secondary sale of: o approximately NZ$3.5 million worth of shares by AF Trust; […]